Structured Field De-Identification
Removing or transforming known identifier fields with date shifting, geographic generalization, and identifier replacement consistent across records for the same patient.
PHI redaction engineers build systems that remove identifiers from clinical data for secondary use. They handle structured fields, free text, and images, apply the de-identification approach your organization has selected, and report residual risk honestly, because automated redaction reduces exposure rather than guaranteeing anonymity.
The central caution is that de-identified is a defined state, not a description of effort. Removing obvious identifiers from a note does not make it de-identified under any recognized standard, and clinical text contains quasi-identifiers that automated detection routinely misses. Engineering reduces risk; the determination that data is adequately de-identified is your organization’s. Our hire dedicated developers hub covers adjacent roles.

Our experts are ready to understand your business goals.






























































The work spans three surfaces that behave differently: structured fields where identifiers are known, free text where they are embedded in prose, and images where they appear in metadata and pixels. The work below reflects that. Residual risk reporting appears prominently because a redaction system that does not quantify what it likely missed provides false assurance.
Removing or transforming known identifier fields with date shifting, geographic generalization, and identifier replacement consistent across records for the same patient.
Detecting names, dates, locations, and contact details embedded in narrative, with recall prioritized since a missed identifier defeats the entire exercise.
Removing identifiers from DICOM metadata and burned-in pixel text, and from scanned documents, since image surfaces are frequently overlooked in redaction programs.
Applying stable replacement so records for the same patient link across sources without exposing identity, where the linkage is required for the intended use.
Measuring detection performance on held-out samples and reporting likely misses, so the organization knows what risk remains rather than assuming none.
Attempting linkage against available data to assess whether the output can be re-identified, which is the practical test of whether redaction achieved anything.
Two recognized approaches exist under HIPAA: removing specified identifier categories, or a qualified expert determining that re-identification risk is very small. Automated redaction supports either but constitutes neither on its own. Engineers who describe their output as de-identified without reference to a determination overstate what was achieved. The context below spans the healthcare work you assign.
HIPAA describes specific approaches. Removing identifiers ad hoc produces data that is less identifiable rather than de-identified, which is a meaningful legal distinction.
Where the statistical approach is used, a qualified person makes the determination. Engineering supplies inputs to that analysis rather than substituting for it.
Automated detection misses identifiers in unusual formats, misspellings, and contextual references. Recall on clinical narrative is never complete.
Rare conditions, unusual dates, and geographic detail can identify individuals even without direct identifiers. Detection focused on names and dates misses this.
DICOM metadata is extensive and some modalities burn text into pixels. Redaction programs addressing only structured data leave imaging exposed.
Aggressive removal produces data nobody can use. The balance between risk reduction and utility is a decision requiring the intended use to be defined first.
This is detection engineering with careful measurement and an honest relationship to its own limits. The differentiating skills are recall optimization on clinical text and residual risk assessment. The competencies below reflect that. Weight measurement and risk reporting above detection breadth, since a system nobody evaluated provides assurance without basis.
Implementing consistent transformations that preserve analytical utility, including date shifting that maintains intervals while removing actual dates.
Building or applying identifier detection tuned for recall on clinical narrative, since a missed name defeats the purpose while a false positive costs only utility.
Handling DICOM tags comprehensively and detecting burned-in text, including secondary capture and screenshot images that frequently retain identifiers.
Evaluating recall and precision on annotated held-out samples from your own documentation, since general performance figures do not predict yours.
Assessing whether output can be linked to identity using available auxiliary data, which is the practical test of adequacy rather than a checklist.
Building redaction into data flows with appropriate controls. Our healthcare integration work covers the source connectivity.
The distinguishing question is what their system missed. Engineers who measured recall know; those who deployed detection without evaluation shipped assurance rather than protection. Our assessment centers on measurement practice and honest risk reporting. Our delivery process includes review points where you can reassess fit.
We ask what recall they achieved on their own documentation. Engineers relying on published detection performance do not know how it performs on their notes.
We ask what their system failed to catch. Specific answers indicate evaluation; engineers reporting no misses have not measured.
We ask how they handled DICOM and scanned documents. Programs addressing only structured data and text leave imaging identifiers untouched.
We ask about rare conditions and unusual dates. Engineers focused only on names and direct identifiers underestimate re-identification risk substantially.
We ask how they described the output. Engineers calling automated output de-identified without reference to a determination overstated what was achieved.
We describe which redaction systems each engineer built and what consumed the output. We do not claim privacy or statistical credentials for engineers.
Engagements should begin with the intended use, because it determines how much utility must survive and therefore how aggressive redaction can be. Structures below reflect that. We also confirm which de-identification approach your organization has selected, since engineering supports a determination rather than making one.
Establishing what the redacted data supports and which de-identification approach applies, since both determine acceptable transformation aggressiveness.
Suits one source and intended use with defined requirements. One engineer maintains consistency in transformation and measurement approach.
De-identification adequacy is your privacy function’s determination. Engagements including them produce output aligned to what the organization will actually accept.
Where you own data flows, staff augmentation adds redaction capability within your existing pipeline standards and governance.
A dedicated healthcare development team builds redaction into data infrastructure so secondary use flows are protected by default.
Where sources and intended use are defined, a fixed-scope build under our engagement models delivers the pipeline with measured detection performance.
Share the intended use, sources involved, and which de-identification approach your privacy function has selected. Utility requirements determine acceptable transformation.
Automated redaction reduces identifiability. Whether the result meets a de-identification standard is a determination your organization makes, in some approaches requiring a qualified expert. We build to HIPAA-aligned practices where HIPAA applies; software cannot be HIPAA certified. We do not provide legal advice or make privacy determinations.
Redaction output is described as processed with measured detection performance and residual risk, not as certified de-identified data, which is not ours to declare.
Recall measured on your own documentation is reported with examples of missed categories, so the organization understands what remains rather than assuming completeness.
Where the statistical approach applies, a qualified expert makes the determination. We supply detection performance and risk analysis as inputs to that assessment.
Redaction covers metadata and burned-in pixel text where imaging is in scope, since programs omitting this leave a well-known exposure path open.
Behavioral health narrative carries higher re-identification sensitivity. We built CHIPSS, a behavioral health system, where such content required strict handling.
We would not describe automated output as de-identified without a determination, present detection as complete removal, or omit residual risk from reporting.
Cost concentrates in detection tuning and measurement rather than pipeline construction. Building annotated evaluation samples from your own documentation is the substantial input and determines whether performance claims mean anything. We publish no figures on detection recall, because that depends on your documentation. What we deliver is measured performance on your own data.
$40,000 to $80,000
Redaction for one data flow with structured transformation, text detection, measurement on your documentation, residual risk reporting, and pipeline integration.
$80,000 to $200,000
Redaction across sources including imaging with consistent pseudonymization, detection tuning, re-identification testing, monitoring, and governance documentation.
Starting at $200,000
Multi-facility redaction infrastructure with varied sources, governance integration, and support for multiple intended uses across clinical environments.
Discovery is paid and time-boxed. It produces a source and surface inventory, detection feasibility assessment on your documentation, utility requirement analysis, and an itemized fixed-scope estimate.
Source count and surface variety including imaging, documentation style, annotation for evaluation, utility preservation requirements, pseudonymization linkage needs, and governance depth.
Documentation practice changes and new sources arrive. Budget for periodic detection revalidation, evaluation sample refresh, and pipeline maintenance as sources evolve.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Expert determination, legal advisory, and privacy assessment are entirely separate from our scope and cost.
Two questions matter. Whether the vendor measures detection on your own notes, and whether they report residual risk rather than declaring data de-identified. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age. Our wider case for Taction sits elsewhere.
We built Voyant Health, an EHR platform. Our healthcare case studies reflect familiarity with where identifiers actually appear in clinical records.
We built CHIPSS, a behavioral health system, where narrative content carried strict disclosure constraints and re-identification sensitivity was heightened.
We built Revive Ease and PainKare, both FDA-registered applications. That work informs how we document detection methodology and limitations.
Taction Software holds ISO 27001 certification covering our information security management practices. It certifies our internal processes and does not determine your privacy position.
Every deployment ships with measured recall and examples of missed categories, which produces less comfortable documentation and prevents unfounded reliance.
That is a determination your organization makes, in some approaches requiring a qualified expert. We describe processing and measured risk rather than declaring a legal state.
We establish the intended use and which de-identification approach your privacy function selected, assess your sources, then present matched engineers for approval.
One data flow runs $40,000 to $80,000, multi-source redaction $80,000 to $200,000, and enterprise infrastructure starts at $200,000. Expert determination and legal advisory are separate.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
We produce processed data with measured detection performance and reported residual risk. Whether it meets a de-identification standard is your organization’s determination, sometimes requiring a qualified expert.
Never complete. Detection misses identifiers in unusual formats and contextual references, and quasi-identifiers such as rare conditions can enable re-identification independently of names.
Redaction transforms real records to reduce identifiability. Synthetic data generates artificial records, which carries different utility characteristics and its own privacy considerations.
Share the intended use, the sources and surfaces involved including imaging, which de-identification approach applies, your utility requirements, and the engagement model you have in mind. We will measure detection on your own documentation and report what it misses. We do not make privacy determinations.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.